01387nam a2200241   45000010005000000100015000051000041000201010008000612000178000692100083002472150023003302250032003533000086003853300465004716060022009366060021009586060024009796060019010036060021010226060022010437100069010658520011011347680  a9291681814  a20040727d2004       y0pory50      ba  aeng  aReport on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugsfEuropean Monitoring Centre for Drugs and Drug Addiction  aLuxembourgcOffice for Official Publications of the European Communitiesd2004  a136 p.cil.d21 cm  aEMCDDA - Risk Assessmentv6  aInformação sobre EMCDDA pode ser encontrada no site: https://www.emcdda.eu.int  aCoucil decision. Cha.1 - Reports on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetyic drugs. Cha.2 - Europol-EMCDDA progress report on 2C-I, 2C-T-2 and 2C-T-7. Cha.3 - Review of the pharmacotoxicological data on 2C-I, 2C-T-2 and 2C-T-7. Cha.4 - Sociological and criminological evidence and public health risks of 2C-I, 2C-T-2 and 2C-T-7. Participants in the risk assessment process. Text of the joint action.  aSAÚDE PÚBLICA  aCONSUMO DE DROGA  aTOXICODEPENDÊNCIA  aTIPOS DE DROGA  aUNIÃO EUROPEIA  aRELATÓRIO ANUAL  aEUROPEAN MONITORING CENTER FOR DRUGS AND DRUG ADDICTION - EMCDDA  jDRO211